Xian Han

Xian Han

Auto-generated profile, based on publicly available information

Xian Han

Department of Structural Biology, St. Jude Children’s Research Hospital

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2023 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
ICInsup Choi
Insup Choi
MWMinghui Wang
Minghui Wang
SYSeungyeul Yoo
Seungyeul Yoo
PXPeng Xu
Peng Xu
SSSteven P. Seegobin
Steven P. Seegobin
ZYZhenyu Yue
Zhenyu Yue

12 October 2022 in Nature Aging
Verified
Journal Article
Closed access
PDF file
PCPing-Chung Chen
Ping-Chung Chen
XHXian Han
Xian Han
TSTimothy I Shaw
Timothy I Shaw
YFYingxue Fu
Yingxue Fu
HSHuan Sun
Huan Sun
JPJunmin Peng
Junmin Peng

3 September 2018 in Cardiology
Verified
Journal Article
Closed access
SHShunying Hu
Shunying Hu
HGHai Gao
Hai Gao
JZJianzhong Zhang
Jianzhong Zhang
XHXian Han
Xian Han
QYQian Yang
Qian Yang
YCYundai Chen
Yundai Chen
Objective: To investigate the association between radiotherapy and anatomic severity of coronary artery disease (CAD) using the SYNTAX scores (SXscores) of coronary angiograms in adult-onset thoracic cancer survivors. Methods: A total of 152 patients who previously had thoracic cancer and underwent coronary angiography between 2010 and 2016 were examined. Propensity score matching (PSM) was used to identify 27 well-matched pairs of patients. Characteristics and coronary angiograms were collected from each patient. Coronary artery abnormalities were assessed using SXscores of coronary angiograms. Results: Among the 152 patients, the SXscores and percentage of high SXscores were higher in the radiotherapy group than in the non-radiotherapy group; however, the latter was not significantly different (p = 0.0266 and p = 0.064, respectively). After PSM, the SXscores and percentage of high SXscores were significantly higher in the radiotherapy group than in the non-radiotherapy group (22 [interquartile range (IQR) 10.00–30.00] vs. 15.00 [IQR 4.00–26.00], p = 0.0459), (70.07 vs. 44.44%, p = 0.027), respectively. After adjusting for related risk factors and chemotherapy, the OR of radiotherapy for a high SXscore was 3.674 (95% CI 1.094–12.343) by logistic regression analysis. Conclusion: Thoracic cancer survivors who underwent radiotherapy have higher SXscores and are at a higher risk of developing anatomically severe CAD, independent of chemotherapy.

25 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JYJay M. Yarbro
Jay M. Yarbro
XHXian Han
Xian Han
ADAbhijit Dasgupta
Abhijit Dasgupta
KYKa Yang
Ka Yang
DLDanting Liu
Danting Liu
JPJunmin Peng
Junmin Peng
Murine models of Alzheimer’s disease (AD) are crucial for elucidating disease mechanisms but have limitations in fully representing AD molecular complexities. We comprehensively profiled age-dependent brain proteome and phosphoproteome ( n > 10,000 for both) across multiple mouse models of amyloidosis. We identified shared pathways by integrating with human metadata, and prioritized novel components by multi-omics analysis. Collectively, two commonly used models (5xFAD and APP-KI) replicate 30% of the human protein alterations; additional genetic incorporation of tau and splicing pathologies increases this similarity to 42%. We dissected the proteome-transcriptome inconsistency in AD and 5xFAD mouse brains, revealing that inconsistent proteins are enriched within amyloid plaque microenvironment (amyloidome). Determining the 5xFAD proteome turnover demonstrates that amyloid formation delays the degradation of amyloidome components, including Aβ-binding proteins and autophagy/lysosomal proteins. Our proteomic strategy defines shared AD pathways, identify potential new targets, and underscores that protein turnover contributes to proteome-transcriptome discrepancies during AD progression.